These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 598783)

  • 21. Chronotropic effects of azelnidipine, a slow- and long-acting dihydropyridine-type calcium channel blocker, in anesthetized dogs: a comparison with amlodipine.
    Fujisawa M; Yorikane R; Chiba S; Koike H
    J Cardiovasc Pharmacol; 2009 Apr; 53(4):325-32. PubMed ID: 19295444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of diltiazem on hemodynamics and His bundle electrogram in the anesthetized dog (author's transl)].
    Nagao T; Murata S; Ikezawa K; Ikeo T; Narita H; Sato M
    Nihon Yakurigaku Zasshi; 1981 Feb; 77(2):195-203. PubMed ID: 7239361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs.
    Uchida W; Hirano Y; Taguchi T; Masuda N; Shirai Y; Satoh N; Takenaka T
    Eur J Pharmacol; 1994 Nov; 264(3):285-93. PubMed ID: 7698167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propanol (ifenprodil) on the cardiovascular system in vivo].
    Mizusawa H; Sakakibara E
    Nihon Yakurigaku Zasshi; 1975 Sep; 71(6):597-608. PubMed ID: 1238330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of the anti-ulcer drug SU-88 on the gastric blood flow and the cardiovascular system (author's transl)].
    Saziki R; Arai I; Isobe Y; Aihara H
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):193-202. PubMed ID: 7084818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3(2H)-isoquinolones. 1. 3-Oxygenated analogs of papaverine as peripheral vasodilators.
    Kreighbaum WE; Kavanaugh WF; Comer WT; Deitchman D
    J Med Chem; 1972 Nov; 15(11):1131-5. PubMed ID: 4654663
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of hemorrhage on regional blood flow distribution in dogs and primates.
    Vatner SF
    J Clin Invest; 1974 Aug; 54(2):225-35. PubMed ID: 4211160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the mechanism of the vasodilator effects of prazosin in dogs and rabbits.
    Cavero I; Fenard S; Gomeni R; Lefevre F; Roach AG
    Eur J Pharmacol; 1978 Jun; 49(3):259-70. PubMed ID: 26580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular effects of brovincamine and possible mechanisms involved.
    Kushiku K; Katsuragi T; Mori R; Morishita H; Furukawa T
    Clin Exp Pharmacol Physiol; 1985; 12(2):121-30. PubMed ID: 4006317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the cardiovascular actions of thalicarpine and its moieties.
    Herman EH; Chadwick DP
    Pharmacology; 1973; 10(3):178-87. PubMed ID: 4202625
    [No Abstract]   [Full Text] [Related]  

  • 31. Investigation on the effect of dipyridamole and papaverine on regional blood flow and cardiac hemodynamics in anesthetized dogs.
    Sakanashi M; Noguchi K; Kato T; Matsuzaki T; Kinjo N; Ikema S; Miyagi H; Moromizato H; Nakasone J; Kinjo Y
    Arzneimittelforschung; 1989 Sep; 39(9):1119-23. PubMed ID: 2590262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional role of alpha-calcitonin gene-related peptide in the regulation of the cardiovascular system.
    Shen YT; Pittman TJ; Buie PS; Bolduc DL; Kane SA; Koblan KS; Gould RJ; Lynch JJ
    J Pharmacol Exp Ther; 2001 Aug; 298(2):551-8. PubMed ID: 11454916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of anti-anginal agents on cyclical reductions of coronary blood flow.
    Uchida Y; Yoshimoto N; Murao S
    Jpn Heart J; 1978 Nov; 19(6):904-12. PubMed ID: 35631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular responses to carotid and vertebral artery infusions of propranolol.
    Stern S; Hoffman M; Braun K
    Cardiovasc Res; 1971 Oct; 5(4):425-30. PubMed ID: 5160448
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs.
    Uchida W; Shibasaki K; Asano M
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):60-8. PubMed ID: 1375689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on the pharmacodynamics of carbochromen].
    Nitz RE
    Arzneimittelforschung; 1970 Mar; 20():433-8. PubMed ID: 4318217
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiovascular effects of nipradilol, a beta-adrenoceptor blocker with vasodilating properties.
    Fujii M; Shirasawa Y; Kondo S; Sawanobori K; Nakamura M
    Jpn Heart J; 1986 Mar; 27(2):233-50. PubMed ID: 2873263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of halothane on the vasomotor tone of the dog's hindlimb (author's transl)].
    Bertoló L; Novakovic L; Penna M
    Arch Biol Med Exp; 1973 Dec; 9(1,2,3):44-9. PubMed ID: 4153199
    [No Abstract]   [Full Text] [Related]  

  • 39. Reversible adrenergic alpha-receptor blocking action of 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone).
    Furuta Y; Yoshikawa A
    Jpn J Pharmacol; 1976 Oct; 26(5):543-50. PubMed ID: 12392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasodilatory and diuretic actions of alpha-human atrial natriuretic polypeptide (alpha-hANP).
    Ishihara T; Aisaka K; Hattori K; Hamasaki S; Morita M; Noguchi T; Kangawa K; Matsuo H
    Life Sci; 1985 Mar; 36(12):1205-15. PubMed ID: 3157037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.